More Post from the Author
- Global Military Products Awarded Contract Exceeding $635 Million for 155mm Artillery Munitions
- SJE Acquires AMI Global, Expanding Industrial Internet of Things (IIoT) Capabilities
- Lumenuity Selected as Finalist for Pepperdine's Most Fundable Companies of 2025
- APhA alarmed by claims of harm from acetaminophen without substantive science
- Exiger Named Presenting Sponsor Of Navy 250 Gala Celebrating Navy & Marine Corps' 250th Anniversary
Alvogen Issues Voluntary Nationwide Recall for One Lot of Fentanyl Transdermal System 25 mcg/h Due to a Defective Delivery System
Published on Mon 3 Feb 2025 2:31:05 UTC
Company Contact Information
Consumers:
866-770-3024
[emailprotected]
Press:
[emailprotected]
MORRISTOWN, N.J., Jan. 31, 2025 /PRNewswire/ -- Alvogen, Inc. is voluntarily recalling one lot of Fentanyl Transdermal System 25 mcg/h transdermal patches to the consumer level. The reason for the recall is that there is a potential that patches could be multi-stacked, adhered one on top of the other, in a single product pouch. This transdermal system is manufactured by Kindeva Drug Delivery L.P., Northridge, CA and is distributed by Alvogen, Inc. as a private label distributor.
More Post from the Author
- Global Military Products Awarded Contract Exceeding $635 Million for 155mm Artillery Munitions
- SJE Acquires AMI Global, Expanding Industrial Internet of Things (IIoT) Capabilities
- Lumenuity Selected as Finalist for Pepperdine's Most Fundable Companies of 2025
- APhA alarmed by claims of harm from acetaminophen without substantive science
- Exiger Named Presenting Sponsor Of Navy 250 Gala Celebrating Navy & Marine Corps' 250th Anniversary